본문 바로가기

Prognostic significance of standardized uptake value on F18-FDG PET/CT in patients with extranodal nasal type NK/T cell lymphoma: A multicenter, retrospective analysis

문서 유형
연구출판물 · 학술지 논문
등재
SCIEScopus
저널 순위
JCR Q4Scopus Q2
저널
AMERICAN JOURNAL OF OTOLARYNGOLOGY39(1) · pp.1 · 2018
피인용
Web of Science 21Scopus 27
FWCI (Scopus)
2.52
JCR IF
JCR 2017 1.046
ISSN
0196-0709

저자

  1. 박경준제1저자Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  2. 김범수Department of Nuclear Medicine and Research Institute for Convergence of Biomedical Science and Technology, Pusan National University Yangsan Hospital, Yangsan, South Korea
  3. 김근영Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  4. 김인주Department of Nuclear Medicine and Biomedical Research Institute, Pusan National University Hospital, Busan, South Korea
  5. Jun, SungminDepartment of Nuclear Medicine, Kosin University Gospel Hospital, Busan, South Korea
  6. Jeong, Young JinDepartment of Nuclear Medicine, Dong-A University Medical Center, Busan, South Korea
  7. Shim, Hye KyungDepartment of Nuclear Medicine, Inje University Haeundae Paik Hospital, Busan, South Korea
  8. 김성동Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea
  9. 조규섭교신저자Department of Otorhinolaryngology and Biomedical Research Institute, Pusan National University School of Medicine, Pusan National University Hospital, Busan, South Korea

초록

Objectives: The purpose of this study was to evaluate the value of parameters assessed with F18-flurodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) in predicting relapse free survival and overall survival in patients with extranodal nasal type NK/T cell lymphoma. Methods: Thirty-six patients with extranodal nasal type NK/T cell lymphoma, and who underwent PET/CT prior to curative treatment, were enrolled at five institutions. Volumes of interest covering the entire tumor volume were delineated on PET/CT images, and the maximum standardized uptake value (SUVmax), mean SUV (SUVmean), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured using thresholds of 40% of SUVmax. Furthermore, we compared the difference in F18-FDG avidity according to Epstein-Barr virus (EBV) infection status. Results: The SUVmax (p = 0.041) and SUVmean (p = 0.049) in patients who died were higher than the respective values of those who survived. A higher TLG (>45.8) was associated with relapse free survival (HR 7.856, p = 0.034). Ann Arbor stage (III-IV, HR 14.12, p = 0.004), and a higher SUVmax (>12.6, p = 0.024) and SUVmean (>6.4, p = 0.024) were associated with poor survival. However, neither the MTV nor the TLG (volumetric parameters) were significant predictors of death. The PET parameters SUVmax (p = 0.181), SUVmean (p = 0.237), MTV (p = 0.636), and TLG (p = 0.469) did not differ significantly between patients with and without EBV infections. Conclusions: High TLG was the only significant predictive factor on relapse free survival. The SUVmax and SUVmean measured by F18-FDG PET/CT could be significant prognostic factors in patients with extranodal nasal type NK/T cell lymphoma. (C) 2017 Elsevier Inc. All rights reserved.

키워드

Epstein-Barr virus infectionsLymphomaExtranodal NK-T-cellFlurodeoxyglucose F18Positron emission tomography computed tomographyPrognosisMETABOLIC TUMOR VOLUMETOTAL LESION GLYCOLYSISEPSTEIN-BARR-VIRUSEMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHYNASOPHARYNGEAL CARCINOMACANCERPARAMETERSHETEROGENEITYOROPHARYNGEALPRETREATMENT

식별자

Scopus EID
2-s2.0-85031751267
WoS UID
000418988600001